The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons

Regional Anesthesia and Pain Medicine

Volumn 38, Issue 1, 2013, Pages 21-27

  Hassan, Bassil ^a,b   Ruiz Velasco, Victor ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; CALCIUM CHANNEL; COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; SODIUM CHANNEL NAV1.8;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROMOTER REGION; RAT; SPINAL GANGLION; WHOLE CELL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BENZENEACETAMIDES; CALCIUM CHANNEL BLOCKERS; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; MALE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SENSORY RECEPTOR CELLS; TETRODOTOXIN;

EID: 84872064748     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e318274a8a1     Document Type: Article

References (24)

1. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:S133YS153.
2. Simonin F, Valverde O, Smadja C, et al. Disruption of the J-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective J-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J. 1998;17:886-897. (Pubitemid 28077643)
3. Wang Y, Sun J, Tao Y, Chi Z, Liu J. The role of J-opioid receptor activation in mediating antinociception addiction. Acta Pharmacol Sin. 2010;31:1065-1070.
4. Rush AM, Cummins TR, Waxman SG. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol. 2007;579:1-14.
5. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 1996;379:257-262.
6. Sangamaswaran L, Delgado SG, Fish LM, et al. Structure and function of a novel voltage-gated tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem. 1996;271:5953-5956. (Pubitemid 26095390)
7. Novakovic SD, Tzoumaka E, McGivern JG, et al. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci. 1998;18:2174-2187. (Pubitemid 28141422)
8. Puhl HL 3rd, Ikeda SR. Identification of the sensory neuron specific regulatory region for the mouse gene encoding the voltage-gated sodium channel NaV1.8. J Neurochem. 2008;106:1209-1224.
9. Ikeda SR. Double-pulse calcium channel current facilitation in adult rat sympathetic neurons. J Physiol. 1991;439:181-214.
10. Altier C, Zamponi GW. Signaling complexes of voltage-gated calcium channels and G protein-coupled receptors. J Recept Signal Transduct Res. 2008;28:71-81. (Pubitemid 351588078)
11. Hille B. Modulation of ion channel function by G-protein coupled receptors. Trends Neurosci. 1994;17:531-535.
12. Kammermeier PJ, Ruiz-Velasco V, Ikeda SR. A voltage-independent calcium current inhibitory pathway activated by muscarinic agonists in rat sympathetic neurons requires both G>q/11 and GAF. J Neurosci. 2000;20:5623-5629. (Pubitemid 30636888)
13. Su X, Joshi SK, Kardos S, Gebhart GF. Sodium channel blocking actions of the J-opioid receptor agonist U50, 488 contribute to its visceral antinociceptive effects. J Neurophysiol. 2002;87:1271-1279. (Pubitemid 34670794)
14. Su X, Castle NA, Antonio B, et al. The effect of J-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons. Anesth Analg. 2009;109:632-640.
15. Joshi SK, Lamb K, Bielfeldt K, Gebhart GF. Arylacetamide J-opioid receptor agonists produce a tonic-and use-dependent block of tetrodotoxin-sensitive and Yresistant sodium currents in colon sensory neurons. J Pharmacol Exp Ther. 2003;307:367-372. (Pubitemid 37151929)
16. Van Derah TW. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain. 2010;26:S10YS15.
17. Mangel AW, Hicks GA. Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clin Exp Gastroenterol. 2012;5:1-10.
18. Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis. 2009;41:854-862.
19. Bradesi S, Herman J, Mayer EA. Visceral analgesics: drugs with a great potential in functional disorders? Curr Opin Pharmacol. 2008;8:697-703.
20. Pugsley MK, Saint DA, Walker MJ. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50488H. Eur J Pharmacol. 1994;261:303-309. (Pubitemid 24267976)
21. Jones DC, Hallyburton I, Stojanovski L, Read KD, Frearson JA, Fairlamb AH. Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis. Biochem Pharmacol. 2010;80:1478-1486.
22. Gschossmann JM, Chaban VV, McRoberts JA, et al. Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by J-opioids. Brain Res. 2000;856:1010-1110.
23. Tallent M, Dichter MA, Bell GI, Reisine T. The cloned opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells. Neurosci. 1994;63:1033-1040. (Pubitemid 24366153)
24. Su X, Wachtel RE, Gebhart GF. Inhibition of calcium currents in rat colon sensory neurons by κ-but not μ-or δ-opioids. J Neurophysiol. 1998;80:3112-3119. (Pubitemid 29029237)